CLGN

COLLPLANT BIOTECHNOLOGIES LT

CLGN·M2R51X116·US·Common Stock·Healthcare - Biotechnology

CLGN (COLLPLANT BIOTECHNOLOGIES LT) is held by 8 institutional investors as of Q2 2026. Largest holders: BROWN ADVISORY INC ($36,541), RENAISSANCE TECHNOLOGIES LLC ($21,457), Pathstone Holdings, LLC ($19,888). Net institutional sentiment: Mixed.

8
Holders
(1 Elite)
$101,668
Total Value
33% (9)
Consensus
3 buying - 6 selling
13F: Insider & Congress: Updated regularly
CLGN

Smart Money Verdict

View all
Loading verdict
Held by 8 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for CLGN.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
104,731(-11.8%)$36,5410.0%-97.25%
0
Increased
61,500(+266.1%)$21,4570.0%-60.72%
21
Unchanged
57,000$19,8880.0%-77.07%
0
Increased
53,700(+67.0%)$18,7360.0%-36.12%
19
Decreased
13,081(-11.6%)$4,5640.0%-77.67%
0
Increased
1,035(+989.5%)$3610.0%-16.73%
12
Unchanged
345$1200.0%-91.46%
0
Unchanged
1$10.0%-90.05%
0
Exited
0(-100.0%)$7,0000.0%-74.10%
0
Exited
0(-100.0%)$630.0%-38.77%
0
Exited
0(-100.0%)$1610.0%-90.32%
0
Exited
0(-100.0%)$7490.0%-88.71%
0
CLGNCLGNCOLLPLANT BIOTECHNOLOGIES LT

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used